Phytopharm PLC
23 September 2005
BLOCKLISTING SIX MONTHLY REVIEW
1. NAME OF COMPANY:
PHYTOPHARM PLC
2. NAME OF SCHEME:
THE PHYTOPHARM 1996 UNAPPROVED DISCRETIONARY SHARE OPTION
3. PERIOD OF RETURN: FROM: TO:
17TH MARCH 2005 16TH SEPTEMBER 2005
4. NUMBER AND CLASS OF SHARE(S)
(AMOUNT OF STOCK/DEBT SECURITY)
NOT ISSUED UNDER SCHEME
AT END OF THE LAST PERIOD:
140,712 ORDINARY SHAES OF 1 PENCE
5. NUMBER OF SHARES ISSUED/ALLOTTED
UNDER SCHEME DURING PERIOD:
NIL
6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED
AT END OF PERIOD:
140,712 ORDINARY SHARES OF 1 PENCE
7. NUMBER AND CLASS OF SHARE(S)
(AMOUNT OF STOCK/DEBT SECURITIES)
ORIGINALLY LISTED AND THE DATE OF ADMISSION:
400,000 ORDINARY SHARES OF 1 PENCE ON 16TH MARCH 2004
PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD
IN ORDER FOR US TO UPDATE OUR RECORDS.
TOTAL SHARES IN ISSUE 51,180,893 ORDINARY SHARES OF 1 PENCE AT 16TH SEPTEMBER
2005
CONTACT FOR QUERIES
NAME: DR G W CHONG
TELEPHONE: 01480 437697
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.